Neurogene
NGNE
25 hedge funds and large institutions have $34.1M invested in Neurogene in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 0 closing their positions.
14% more funds holding
Funds holding: 22 → 25 (+3)
9% more capital invested
Capital invested by funds: $31.2M → $34.1M (+$2.91M)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$254K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$190K |
| 3 |
SIM
Spark Investment Management
New York
|
+$43.7K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$39.6K |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$16.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$446K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$306K |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$231K |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$204K |
| 5 |
RA
Royce & Associates
New York
|
-$179K |
NGNE Hedge Fund Activity: Q1 2015 in Review
25 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q1 2015, worth a combined $34.1M — up 9.3% from $31.2M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NGNE positions and 0 closed out — a net gain of 3 holders — while 5 added to existing stakes and 9 trimmed.
The largest buyer was Visium Asset Management, adding an estimated $254K. The largest seller was Driehaus Capital Management, cutting an estimated $446K.
- 25 institutional investors held Neurogene (NGNE) as of Q1 2015, up from 22 in Q4 2014.
- Funds reported $34.1M of Neurogene stock for Q1 2015, up 9.3% quarter-over-quarter.
- 3 funds opened new Neurogene positions in Q1 2015 and 0 closed out, a net change of +3 holders.
- The largest Neurogene buyer in Q1 2015 was Visium Asset Management, an estimated $254K added.
- The largest Neurogene seller in Q1 2015 was Driehaus Capital Management, an estimated $446K sold.
Based on aggregated 13F filings for Q1 2015.